EP2575881
ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2011EP published:
14.9.2016EP application number:
11728594.0
EPO information:
European Patent Register
Max expiry date:
26.5.2031
Title:
ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
Timeline
Today
27.5.2011EP application
14.9.2016EP Publication
Owner
Name:
INSERM - Institut National de la Santé et de la Recherche MédicaleAddress:
101, rue de Tolbiac, 75013, Paris, FR
Name:
Elsalys BiotechAddress:
321 avenue Jean Jaures, 69007, Lyon, FR
Inventor
Name:
LE BOUTEILLER, PhilippeAddress:
F-31024 Toulouse Cédex 3, FR
Name:
BENSUSSAN, ArmandAddress:
Paris, FR
Priority
Number:
349271 PDate:
28.5.2010Country:
US
Classification
Categories:
A61K 39/00, A61K 9/00, A61K 39/395, A61P 27/02, C07K 16/28, C07K 16/22